Screener
Janux Therapeutics JANX Total Revenue
Total Revenue at other companies
Other financials
Where this comes from
Reported directly by Janux Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax.
The source filing: Janux Therapeutics’s 10-Q, filed August 6, 2026.
- Filed
- Aug 6, 2026, 4:18 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-338078
| Line item | Three Months Ended June 30, 2026 | Three Months Ended June 30, 2025 | Six Months Ended June 30, 2026 | Six Months Ended June 30, 2025 |
|---|---|---|---|---|
| Collaboration revenue | $10,267 | — | $14,000 | — |
| Operating expenses: | ||||
| Research and development | 30,994 | 34,664 | 57,807 | 59,719 |
| General and administrative | 10,963 | 10,454 | 22,096 | 20,296 |
| Total operating expenses | 41,957 | 45,118 | 79,903 | 80,015 |
| Loss from operations | (31,690) | (45,118) | (65,903) | (80,015) |
| Other income: | ||||
| Interest income | 9,718 | 11,260 | 19,570 | 22,649 |
Item 1. Financial Statements.
FAQ
- What is Janux Therapeutics's total revenue?
- Janux Therapeutics (JANX) reported total revenue of $10.27M in Q2 2026.
- What is the long-term trend for Janux Therapeutics's total revenue?
- Over 4 years (2021 to 2025), Janux Therapeutics's total revenue has grown at a 28.8% compound annual growth rate (CAGR), from $3.64M to $10M.
- What does total revenue mean?
- The aggregate of all revenue from the company's operations — the top line from which all profitability metrics are derived.
Ask your AI about Janux Therapeutics's total revenue.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude